Overview
Working together in partnership to support clinical decision-making Doris-Ann Williams MBE – Chief Executive, British In Vitro Diagnostics Association
Welcome to The Biomedical Science Industry Handbook 2020. I hope it proves useful to keep to hand with all the information you may need about the suppliers supporting NHS pathology services. This is the third year I have been asked to write this overview so I am in danger of repeating myself! However, the work that you do as biomedical scientists is worth repeating as it underpins the healthcare provided to us all when we are in need of treatment. With increasing need to take money out of the system from your side and for industry to meet the financial demands of increased regulation, employee accreditation to access NHS trust sites, and to ensure continuity of supply in the case of a No Deal Brexit, it would be easy for us to lose sight of the very thing we all need to do in the coming year – work together in partnership to ensure the best possible information is provided to support clinical decision-making. The environment will continue to be uncertain. We have to recognise this and work through the challenges ahead as we leave the EU,
It is important to recognise that some of the amazing work goes on with some really good and underutilised products
THE BIOMEDICAL SCIENCE INDUSTRY HANDBOOK 2020 l 9
and instead focus on being the best patient-centred service we can be. It is also frustrating to see
policy-makers excited by shiny new things, overlooking some of the amazing work that goes on with some really good and underutilised products. Baroness Harding, as Chair of NHS Improvement, is keen to encourage what she terms ’copying’ to ensure more equitable access to the NHS, and I applaud that and hope she is successful. We, in laboratory medicine, were at the forefront of being digital – all the output you provide are data and with better connectivity and joined up community and hospital records, this will be of more value – the apps and other new pieces of kit will have their place, but we should not let them outshine the work being done in biomedical science.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
